1. Rab35-regulated lipid turnover by myotubularins represses mTORC1 activity and controls myelin growth
- Author
-
Kerstin Klinkert, Volker Haucke, Alessandra Bolino, Genaro Patino-Lopez, Linda Sawade, Francina Langa-Vives, Federica Grandi, Marianna Mignanelli, Roberta Di Guardo, Arnaud Echard, Leibniz Forschungsinstitut für Molekulare Pharmakolgie = Leibniz Institute for Molecular Pharmacology [Berlin, Allemagne] (FMP), Leibniz Association, IRCCS Ospedale San Raffaele [Milan, Italy], Universita Vita Salute San Raffaele = Vita-Salute San Raffaele University [Milan, Italie] (UniSR), Hospital Infantil de México Federico Gómez (HIMFG), Trafic membranaire et Division cellulaire - Membrane Traffic and Cell Division, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Sorbonne Université (SU), Centre d'Ingénierie génétique murine - Mouse Genetics Engineering Center (CIGM), Institut Pasteur [Paris] (IP), Freie Universität Berlin, Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Supported by grants from the German Research Foundation (DFG) (SFB958/A01 and HA2686/15-1 to V.H.), from Muscular Dystrophy Association (MDA574294) and AFM-Telethon France (#21528) to A.B., V.H. and A.B. are funded by E-Rare-3 JTC 2017 and are members of the eRARE Consortium 'Treat-MTMs'. Part of this work has been supported by Institut Pasteur and CNRS to A.E., K.K. was supported by the Pasteur - Paris University (PPU) International PhD Program and by and a fellowship from FRM (FDT20150532389)., Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), and Institut Pasteur [Paris]
- Subjects
0301 basic medicine ,Myelin biology and repair ,General Physics and Astronomy ,GTPase ,mTORC1 ,[SDV.BC.BC]Life Sciences [q-bio]/Cellular Biology/Subcellular Processes [q-bio.SC] ,Small GTPases ,chemistry.chemical_compound ,Myelin ,0302 clinical medicine ,Charcot-Marie-Tooth Disease ,Gene Knock-In Techniques ,Lipid signalling ,lcsh:Science ,Myelin Sheath ,Multidisciplinary ,Hyperactivation ,Chemistry ,Protein Tyrosine Phosphatases, Non-Receptor ,Phenotype ,3. Good health ,Cell biology ,medicine.anatomical_structure ,Signal Transduction ,congenital, hereditary, and neonatal diseases and abnormalities ,Science ,Primary Cell Culture ,Down-Regulation ,Mice, Transgenic ,Mechanistic Target of Rapamycin Complex 1 ,General Biochemistry, Genetics and Molecular Biology ,Article ,03 medical and health sciences ,medicine ,Animals ,Humans ,Phosphatidylinositol ,Gene ,General Chemistry ,Nutrient signalling ,Lipid Metabolism ,nervous system diseases ,030104 developmental biology ,HEK293 Cells ,rab GTP-Binding Proteins ,Astrocytes ,Mutation ,lcsh:Q ,030217 neurology & neurosurgery ,Biogenesis ,HeLa Cells - Abstract
Inherited peripheral neuropathies (IPNs) represent a broad group of disorders including Charcot-Marie-Tooth (CMT) neuropathies characterized by defects primarily arising in myelin, axons, or both. The molecular mechanisms by which mutations in nearly 100 identified IPN/CMT genes lead to neuropathies are poorly understood. Here we show that the Ras-related GTPase Rab35 controls myelin growth via complex formation with the myotubularin-related phosphatidylinositol (PI) 3-phosphatases MTMR13 and MTMR2, encoded by genes responsible for CMT-types 4B2 and B1 in humans, and found that it downregulates lipid-mediated mTORC1 activation, a pathway known to crucially regulate myelin biogenesis. Targeted disruption of Rab35 leads to hyperactivation of mTORC1 signaling caused by elevated levels of PI 3-phosphates and to focal hypermyelination in vivo. Pharmacological inhibition of phosphatidylinositol 3,5-bisphosphate synthesis or mTORC1 signaling ameliorates this phenotype. These findings reveal a crucial role for Rab35-regulated lipid turnover by myotubularins to repress mTORC1 activity and to control myelin growth., Charcot-Marie-Tooth (CMT) is an inherited peripheral neuropathy. Here, the authors show that Rab35 forms a complex with genes implicated in CMT, MTMR13 and MTMR2, which regulates myelin growth by controlling mTORC1 signaling through lipid turnover.
- Published
- 2020
- Full Text
- View/download PDF